(Q45393757)

English

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis.

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

liver cirrhosis

0 references

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Eliya Syed

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Nogol Rahbin

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tony Carlsson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Antti Oksanen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Markus Birk

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Loa Davidsdottir

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Karin Hagen

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Rolf Hultcrantz

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 January 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

43

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1378-1386

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b.

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study.

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation.

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

1 reference

https://api.crossref.org/works/10.1080%2F00365520802245395

21 January 2018

Identifiers

10.1080/00365520802245395

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615358%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45393757&oldid=1562853039"